Fig. 2From: Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis—with an illustrative case of HIV treatment in MozambiqueCost-effectiveness acceptability curves for HIV treatment approaches in Mozambique from the A patient perspective and B health sector perspective. ARV antiretroviral drug, DALY disability-adjusted life year, GDP gross domestic product, LTFU lost to follow-upBack to article page